|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.956 EUR | +6.82% |
|
+11.16% | +20.10% |
Lavipharm S.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 57.43 million compared to EUR 45.14 million a year ago. Revenue was EUR 50.93 million compared to EUR 39.06 million a year ago.
Net income was EUR 1.87 million compared to EUR 0.83 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +20.10% | 163M | |
| +21.28% | 44.4B | |
| +24.47% | 23.03B | |
| +19.22% | 15.14B | |
| +12.87% | 13.12B | |
| +44.67% | 11.85B | |
| -9.92% | 6.99B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +13.07% | 5.52B |
LAVIPHARM S.A. 